RLYB
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Stock is cheap relative to assets but prohibitively expensive relative to revenue.
- P/B ratio of 0.75
- P/S ratio of 50.68
- No Graham Number due to lack of earnings
Growth is present in revenue but not translating to bottom-line viability.
- High YoY revenue growth (484%)
- Negative EPS progression
- High burn rate
Long-term value destruction despite recent speculative volatility.
- Strong 1-year price recovery (+311%)
- Devastating 5-year return (-92.7%)
- Consistent quarterly losses
Balance sheet is liquid, but the business model is fundamentally unhealthy.
- Zero debt
- High current ratio
- Piotroski F-Score: 0/9
- Negative ROE and ROA
Non-dividend paying growth/biotech entity.
- No dividend payments
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for RLYB and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
RLYB
Rallybio Corporation
Primary
|
-92.7% | -76.3% | +311.0% | +92.1% | -12.2% | -2.6% |
|
ARAY
Accuray Incorporated
Peer
|
-93.2% | -87.0% | -78.7% | -76.4% | -27.4% | -24.4% |
|
APLM
Apollomics, Inc.
Peer
|
-98.0% | -98.1% | +148.8% | +191.4% | -0.5% | -0.8% |
|
RNXT
RenovoRx, Inc.
Peer
|
-86.2% | -68.2% | -2.0% | -10.7% | -2.9% | +1.5% |
|
INCR
InterCure Ltd.
Peer
|
-91.7% | -67.4% | -37.5% | -52.3% | -4.7% | +0.4% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
RLYB
Rallybio Corporation
|
BEARISH | $43.48M | - | -15.0% | -% | $8.22 | |
|
ARAY
Accuray Incorporated
|
BEARISH | $44.0M | - | -70.3% | -8.2% | $0.37 | Compare |
|
APLM
Apollomics, Inc.
|
BEARISH | $42.65M | - | -380.1% | -% | $19.9 | Compare |
|
RNXT
RenovoRx, Inc.
|
BEARISH | $45.05M | - | -225.6% | -% | $1.0 | Compare |
|
INCR
InterCure Ltd.
|
BEARISH | $41.72M | - | -16.7% | -29.2% | $0.76 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning RLYB from our newsroom.